Drug and Alcohol Services, South East Sydney Local Health District, Sydney, Australia.
School of Public Health and Community Medicine, UNSW Sydney, Sydney, Australia.
Drug Alcohol Rev. 2021 May;40(4):567-571. doi: 10.1111/dar.13228. Epub 2021 Jan 21.
Buprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone). There is little documented experience regarding the management of precipitated withdrawal. In our case, a patient developed a significant precipitated opioid withdrawal following buprenorphine administration, and was able to be successfully treated in hospital with further buprenorphine. This demonstrates that rapid increases in buprenorphine dose can be used as an effective treatment for buprenorphine-induced precipitated opioid withdrawal. The use of buprenorphine to manage withdrawal then allows the individual to continue on this highly effective treatment.
丁丙诺啡是一种常用的阿片类部分激动剂,用于治疗阿片类药物依赖。丁丙诺啡的药理学增加了开始使用丁丙诺啡治疗的患者出现阿片类药物戒断的风险,特别是当从长效阿片类药物(如美沙酮)转换时。关于管理急性戒断的经验记录很少。在我们的病例中,患者在给予丁丙诺啡后出现明显的急性阿片类药物戒断,随后在医院成功接受进一步的丁丙诺啡治疗。这表明丁丙诺啡剂量的快速增加可用于有效治疗丁丙诺啡引起的急性阿片类药物戒断。然后使用丁丙诺啡来管理戒断,使个体能够继续接受这种高效治疗。